ET-1 contributes to pulmonary vascular remodeling, potentially leading to pulmonary arterial hypertension (PAH) secondary to bleomycin (BLM)-induced PF (14, 18). This evidence concerns the gene EDN1 and pulmonary arterial hypertension.